KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Change in Cash (2016 - 2025)

Historic Change in Cash for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $778.0 million.

  • Elevance Health's Change in Cash rose 6623.93% to $778.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 billion, marking a year-over-year decrease of 3419.04%. This contributed to the annual value of $1.2 billion for FY2025, which is 3419.04% down from last year.
  • Latest data reveals that Elevance Health reported Change in Cash of $778.0 million as of Q4 2025, which was up 6623.93% from $153.0 million recorded in Q3 2025.
  • In the past 5 years, Elevance Health's Change in Cash ranged from a high of $3.6 billion in Q1 2021 and a low of -$4.4 billion during Q4 2023
  • In the last 5 years, Elevance Health's Change in Cash had a median value of $293.5 million in 2022 and averaged $190.8 million.
  • Its Change in Cash has fluctuated over the past 5 years, first tumbled by 69560.76% in 2021, then soared by 94137.93% in 2022.
  • Quarter analysis of 5 years shows Elevance Health's Change in Cash stood at -$610.0 million in 2021, then crashed by 143.44% to -$1.5 billion in 2022, then plummeted by 195.82% to -$4.4 billion in 2023, then skyrocketed by 110.65% to $468.0 million in 2024, then soared by 66.24% to $778.0 million in 2025.
  • Its Change in Cash was $778.0 million in Q4 2025, compared to $153.0 million in Q3 2025 and $1.1 billion in Q2 2025.